These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37590197)

  • 1. Airway and Oral microbiome profiling of SARS-CoV-2 infected asthma and non-asthma cases revealing alterations-A pulmonary microbial investigation.
    Sekaran K; Varghese RP; Doss C GP; Alsamman AM; Zayed H; El Allali A
    PLoS One; 2023; 18(8):e0289891. PubMed ID: 37590197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome.
    Rosas-Salazar C; Kimura KS; Shilts MH; Strickland BA; Freeman MH; Wessinger BC; Gupta V; Brown HM; Rajagopala SV; Turner JH; Das SR
    J Allergy Clin Immunol; 2021 Apr; 147(4):1226-1233.e2. PubMed ID: 33577896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 alters human microbiomes: a meta-analysis.
    Reuben RC; Beugnon R; Jurburg SD
    Front Cell Infect Microbiol; 2023; 13():1211348. PubMed ID: 37600938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Microbiome Alterations and SARS-CoV-2 Saliva Viral Load in Patients with COVID-19.
    Miller EH; Annavajhala MK; Chong AM; Park H; Nobel YR; Soroush A; Blackett JW; Krigel A; Phipps MM; Freedberg DE; Zucker J; Sano ED; Uhlemann AC; Abrams JA
    Microbiol Spectr; 2021 Oct; 9(2):e0005521. PubMed ID: 34643448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The salivary and nasopharyngeal microbiomes are associated with SARS-CoV-2 infection and disease severity.
    Kim JG; Zhang A; Rauseo AM; Goss CW; Mudd PA; O'Halloran JA; Wang L
    J Med Virol; 2023 Feb; 95(2):e28445. PubMed ID: 36583481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasopharyngeal microbiome reveals the prevalence of opportunistic pathogens in SARS-CoV-2 infected individuals and their association with host types.
    Gupta A; Karyakarte R; Joshi S; Das R; Jani K; Shouche Y; Sharma A
    Microbes Infect; 2022 Feb; 24(1):104880. PubMed ID: 34425246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diversity, composition, and networking of saliva microbiota distinguish the severity of COVID-19 episodes as revealed by an analysis of 16S rRNA variable V1-V3 region sequences.
    Larios Serrato V; Meza B; Gonzalez-Torres C; Gaytan-Cervantes J; González Ibarra J; Santacruz Tinoco CE; Anguiano Hernández YM; Martínez Miguel B; Cázarez Cortazar A; Sarquiz Martínez B; Alvarado Yaah JE; Mendoza Pérez AR; Palma Herrera JJ; García Soto LM; Chávez Rojas AI; Bravo Mateos G; Samano Marquez G; Grajales Muñiz C; Torres J
    mSystems; 2023 Aug; 8(4):e0106222. PubMed ID: 37310423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in the nasopharyngeal microbiome associated with SARS-CoV-2 infection status and disease severity.
    Gauthier NPG; Locher K; MacDonald C; Chorlton SD; Charles M; Manges AR
    PLoS One; 2022; 17(10):e0275815. PubMed ID: 36240246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Infection is Associated with Age- and Gender-Specific Changes in the Nasopharyngeal Microbiome.
    Bozza S; Nunzi E; Frias-Mazuecos A; Pieraccini G; Pariano M; Renga G; Mencacci A; Talesa VN; Antognelli C; Puccetti P; Romani L; Costantini C
    Front Biosci (Landmark Ed); 2024 Feb; 29(2):59. PubMed ID: 38420819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-Related Changes in the Nasopharyngeal Microbiome Are Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Symptoms Among Children, Adolescents, and Young Adults.
    Hurst JH; McCumber AW; Aquino JN; Rodriguez J; Heston SM; Lugo DJ; Rotta AT; Turner NA; Pfeiffer TS; Gurley TC; Moody MA; Denny TN; Rawls JF; Clark JS; Woods CW; Kelly MS
    Clin Infect Dis; 2022 Aug; 75(1):e928-e937. PubMed ID: 35247047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization.
    Wu Y; Cheng X; Jiang G; Tang H; Ming S; Tang L; Lu J; Guo C; Shan H; Huang X
    NPJ Biofilms Microbiomes; 2021 Jul; 7(1):61. PubMed ID: 34294722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring nasopharyngeal microbiota profile in children affected by SARS-CoV-2 infection.
    Romani L; Del Chierico F; Pane S; Ristori MV; Pirona I; Guarrasi V; Cotugno N; Bernardi S; Lancella L; Perno CF; Rossi P; Villani A; Campana A; Palma P; Putignani L;
    Microbiol Spectr; 2024 Mar; 12(3):e0300923. PubMed ID: 38289047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited Impact of SARS-CoV-2 on the Human Naso-Oropharyngeal Microbiota in Hospitalized Patients.
    Lai CKC; Cheung MK; Lui GCY; Ling L; Chan JYK; Ng RWY; Chan HC; Yeung ACM; Ho WCS; Boon SS; Chan PKS; Chen Z
    Microbiol Spectr; 2022 Dec; 10(6):e0219622. PubMed ID: 36350127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of co-circulating pathogens and microbiome from COVID-19 infections.
    Thissen JB; Morrison MD; Mulakken N; Nelson WC; Daum C; Messenger S; Wadford DA; Jaing C
    PLoS One; 2022; 17(12):e0278543. PubMed ID: 36455065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in the oral microbiome of individuals with a healthy oral environment following COVID-19 vaccination.
    Uehara O; Abiko Y; Nagasawa T; Morikawa T; Hiraki D; Harada F; Kawano Y; Toraya S; Matsuoka H; Paudel D; Shimizu S; Yoshida K; Asaka M; Furuichi Y; Miura H
    BMC Oral Health; 2022 Mar; 22(1):50. PubMed ID: 35241064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 detection status associates with bacterial community composition in patients and the hospital environment.
    Marotz C; Belda-Ferre P; Ali F; Das P; Huang S; Cantrell K; Jiang L; Martino C; Diner RE; Rahman G; McDonald D; Armstrong G; Kodera S; Donato S; Ecklu-Mensah G; Gottel N; Salas Garcia MC; Chiang LY; Salido RA; Shaffer JP; Bryant MK; Sanders K; Humphrey G; Ackermann G; Haiminen N; Beck KL; Kim HC; Carrieri AP; Parida L; Vázquez-Baeza Y; Torriani FJ; Knight R; Gilbert J; Sweeney DA; Allard SM
    Microbiome; 2021 Jun; 9(1):132. PubMed ID: 34103074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saliva microbiome in relation to SARS-CoV-2 infection in a prospective cohort of healthy US adults.
    Armstrong AJS; Horton DB; Andrews T; Greenberg P; Roy J; Gennaro ML; Carson JL; Panettieri RA; Barrett ES; Blaser MJ
    EBioMedicine; 2023 Aug; 94():104731. PubMed ID: 37487417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection.
    Romani L; Del Chierico F; Macari G; Pane S; Ristori MV; Guarrasi V; Gardini S; Pascucci GR; Cotugno N; Perno CF; Rossi P; Villani A; Bernardi S; Campana A; Palma P; Putignani L;
    Front Cell Infect Microbiol; 2022; 12():908492. PubMed ID: 35873161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal Microbiome in COVID-19: A Potential Role of Corynebacterium in Anosmia.
    Nardelli C; Scaglione GL; Testa D; Setaro M; Russo F; Di Domenico C; Atripaldi L; Zollo M; Corrado F; Salvatore P; Pinchera B; Gentile I; Capoluongo E
    Curr Microbiol; 2022 Dec; 80(1):53. PubMed ID: 36583787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human microbiota dysbiosis after SARS-CoV-2 infection have the potential to predict disease prognosis.
    Zhou J; Yang X; Yang Y; Wei Y; Lu D; Xie Y; Liang H; Cui P; Ye L; Huang J
    BMC Infect Dis; 2023 Nov; 23(1):841. PubMed ID: 38031010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.